Zusammenfassung
In verschiedenen Populationen, bei denen eine arterielle Hypertonie diagnostiziert wird, müssen einige Besonderheiten bei der Auswahl, Dosierung, Einleitung und/oder Durchführung der antihypertensiven Therapie beachtet werden.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Adelman RD, Coppo R, Dillon MJ (2000) The emergency of severe hypertension. Pediatr Nephrol 14:422–427
August P, Oparil S (1999) Hypertension in women. J Clin Endocrinol Metab 84:1862–1866
Bonapace S, Rajkumar C, Bulpitt CJ (1998) Tailoring antihypertensive treatment in the elderly. J Hum Hypertension 12:615–620
Campese VM, Parise M, Karubian F, Bigazzi R (1991) Abnormal renal hemodynamics in black salt-sensitive patients with hypertension. Hypertension 18:805–816
Chalmers J, Castaigne A, Morgan T, Chastang C (2000) Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients. J Hypertension 18:327–337
Cholley BP, Shroff SG, Sandelski J, Korcarz C, Balasia BA, Jain S, Berger DS, Murphy MB, Marcus RH, Lang RM (1995) Differential effects of chronic oral antihypertensive therapies on systemic arterial circulation and ventricular energetics in African-American patients. Circulation 91:1052–1062
Dahlöf B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO (1991) Morbidity and mortality in the Swedish Trial in Older Patients with Hypertension (STOP-Hyperten-sion). Lancet 338:1281–1285
Deutsche Liga zur Bekämpfung des hohen Blutdruckes e.V. Deutsche Hypertonie Gesellschaft (1999) Hochdruck in der Schwangerschaft und während der Stillperiode. Merkblatt, 4. Auflage, Heidelberg
Duley L, Henderson-Smart DJ (2000) Drugs for rapid treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev CD001449
Ergul A (2000) Hypertension in black patients. An emerging role of the endothelin system in salt-sensitive hypertension. Hypertension 36:62–67
Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, Clement D, de Leeuw PW, Dobovisek J, Jääskivi M, Leonetti G, O’Brien E, Palatini P, Paranti G, Rodicio JL, Vanhanen H, Webster J for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators (2000) Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Circulation 102:1139–1144
Fernandes E, McCrindle BW (2000) Diagnosis and treatment of hypertension in children and adolescents. Can J Cardiol 16:801–811
Fischer T, Schmieder RE, Aepfelbacher FC, Messerli FH (1995) Antihypertensive therapy in hypertensive postmenopausal women. In: Messerli FH (ed) Hypertension in postmenopausal women. Marcel Dekker, New York, pp 241–266
Fröhlich ED (1992) Obesity hypertension. Converting enzyme inhibitors and calcium antagonists. Hypertension 19(suppl I):I-119-1-123
Gallery EDM (1995) Hypertension in pregnancy. Practical management recommendations. Drugs 49:555–562
Garavaglia GE, Messerli FH, Schmieder RE, Nunez BD, Oren S (1989) Sex differences in cardiac adaptation to essential hypertension. Europ Heart J 10:1110–1114
Glynn RJ, Field TS, Rosner B, Hebert PR, Taylor JO, Hennekens CH (1995) Evidence for a positive linear relation between blood pressure and mortality in elderly people. Lancet 345:825–829
Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL for the Atherosclerosis Risk in Communities Study (2000) Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. N Engl J Med 342:905–912
Guidelines Sub-Committee (1999) World Health Organisation-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertension 17:151–183
Hall WD, Reed JW, Flack JM, Yunis C, Preisser J, and the ISHIB Investigators Group (1998) Comparison of the efficacy of dihydropyridine calcium channel blockers in African American patients with hypertension. Arch Intern Med 158:2029–2034
Hansson L, Lindholm LH, Ekbom T, Dahlöf B, Lanke J, Scherstén B, Wester P-O, Hedner T, de Faire U for the STOP-Hypertension-2 study group (1999) Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity in the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 354:1751–1756
Harris RZ, Benet LZ, Schwartz JB (1995) Gender effects in pharmacokinetics and pharmacodynamics. Drugs 50:222–239
Hsueh WA, Buchanan TA (1994) Obesity and hypertension. Endocrinol Metab Clin N Amer 23:405–427
Jamerson K, De Quattro V (1996) The impact of ethnicity on response to antihypertensive therapy. Am J Med 101(suppl 3A):22S–32S
Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (1997) The Sixth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 157:2413–2446
Kando JC, Yonkers KA, Cole JO (1995) Gender as a risk factor for adverse events to medications. Drugs 50:1–6
Klüngel OH, de Boer A, Paes AHP, Seidell JC, Bakker A (1997) Sex differences in the pharmacological treatment of hypertension: a review of population-based studies. J Hypertension 15:591–600
Kuch B, Muscholl M, Luchner A, Döring A, Riegger GAJ, Schunkert H, Hense H-W (1998) Gender differences in left ventricular adaptation to obesity and hypertension. J Hum Hypertension 12:685–691
Laville M, Lengani A, Serme D, Fauvel JP, Ouandaogo BJ, Zech P (1994) Epidemiological profile of hypertensive disease and renal risk factors in Black Africa. J Hypertension 12:839–843
Lever AF, Ramsay LE (1995) Treatment of hypertension in the elderly. J Hypertension 13:571–579
Lydakis C, Lip GYH, Beevers M, Beevers DG (1999) Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertension 12:541–547
Messerli FH, Garavaglia GE, Schmieder RE, Sundgaard-Riise K, Nunez BD, Amodeo C (1987) Disparate cardiovascular findings in men and women with essential hypertension. Ann Intern Med 107:158–161
Mosca L (2000) The role of hormone replacement therapy in the prevention of postmenopausal heart disease. Arch Intern Med 160:2263–2272
MRC Working Party (1992) Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 304:405–412
National High Blood Pressure Education Program (NHBPEP) Working Group on Hypertension Control in Children and Adolescents (1996) Update on the 1987 task force report on high blood pressure in children and adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics 98:649–658
Pahor M, Shorr RI, Somes GW, Cushman WC, Ferrucci L, Bailey JE, Elam JT, Applegate WB (1998) Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the Systolic Hypertension in the Elderly Program. Arch Intern Med 158:1340–1345
Perry HM, Davis BR, Price TR, Applegate WB, Fields WS, Guralnik JM, Kuller L, Pressel S, Stamler J, Probstfield JL for the Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group (2000) Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke. The Systolic Hypertension in the Elderly Program (SHEP). JAMA 284:465–471
Pickering TG (1999) Advances in the treatment of hypertension. JAMA 281:114–116
Pines A, Fisman EZ, Levo Y, Drory Y, Ben-Ari E, Motro M, Ayalon D (1993) Menopause-in-duced changes in left ventricular wall thickness. Am J Cardiol 72:240–241
Prince MJ, Bird AS, Blizard RA, Mann AH (1996) Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council’s treatment trial of hypertension in older adults. Br Med J 312:801–805
Prisant LM, Moser M (2000) Hypertension in the elderly. Can we improve results of therapy? Arch Intern Med 160:283–289
Proudler AJ, Hasib Ahmed AI, Crook D, Fogelman I, Rymer JM, Stevenson JC (1995) Hormone replacement therapy and serum angiotensin-converting enzyme activity in postmenopausal women. Lancet 346:89–90
Rey É, Le Lorier J, Burgess E, Lange IR, Leduc L (1997) Report of the Canadian Hypertension Society Consensus Conference: 3. Pharamcologic treatment of hypertensive disorders in pregnancy. Can Med Ass J 157:1245–1254
Roberts JM, Redman CWG (1993) Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 341:1447–1454
Rutledge DR (1994) Race and hypertension. Drugs 47:914–932
Safar M, Stimpel M, Zanchetti A (Hrsg) (1994) Hypertension in postmenopausal women. Springer Berlin New York Tokyo
Saunders E, Weir MR, Kong BW, Hollifield J, Gray J, Vertes V, Sowers JR, Zemel MB, Curry C, Schoenberger J, Wright JT, Kirkendall W, Conradi EC, Jenkins P, McLean B, Massie B, Berenson G, Flamenbaum W (1990) A comparison of the efficacy and safety of a betablocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med 150:1707–1713
Schmieder RE, Gatzka C, Schächinger H, Schobel H, Rüddel H (1993) Obesity as a determinant for response to antihypertensive treatment. Br Med J 307:537–540
Seedat YK (1998) The prevalence of hypertension and the status of cardiovascular health in South Africa. Ethnicity Dis 8:394–397
SHEP Cooperative Research Group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265:3255–3264
Sibai BM (1996) Treatment of hypertension in pregnant women. N Engl J Med 336:257–265
Silvestrini M, Vernieri F, Pasqualetti P, Matthies M, Passarelli F, Troidi E, Caltagirone C (2000) Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA 283:2122–2127
Sinaiko AR (1993) Pharmacologie management of childhood hypertension. Ped Clin N Am 40:195–212
Staessen J, Bulpitt C, Clement D, De Leeuw P, Fagard R, Fletcher A, Forette F, Leonetti G, Nissinen A, O’Malley K, Tuomiletho J, Webster J, Williams BO (1989) Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly. Br Med J 298:1552–1556
Stimpel M, Zanchetti A (Hrsg) (1997) Hypertension after menopause. Walter de Gruyter, Berlin New York
Stimpel M, Koch B, Oparil S (1998) Antihypertensive treatment in postmenopausal women: results from a prospective, randomized, double-blind, controlled study comparing an ACE inhibitor (moexipril) with a diuretic (hydrochlorothiazide). Cardiology 89:271–276
Stimpel M, Koch B, Weber MA (1998) Comparison between moexipril and atenolol in obese postmenopausal women with hypertension. Maturitas 30:69–77
Temple ME, Nahata MC (2000) Treatment of pediatric hypertension. Pharmacotherapy 20:140–150
Tuomilehto J, Rastenyte D, Birkenhäger WH, Thiijs L, Antikainen R, Bulpitt CJ, Fletcher AE, Forette F, Goldhaber A, Palatini P, Sarti C, Fagard R for the Systolic Hypertension in Europe Trial Investigators (1999) Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med 340:677–684
Van den Hoogen PCW, Feskens EJM, Nagelkerke NJD, Menotti A, Nissinen A, Kromhout D for the Seven Countries Study Research Group (2000) The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. N Engl J Med 342:1–8
Wang LL, Staessen JA, Gong L, Liu L for the Systolic Hypertension in China (Syst-China) Collaborative Group (2000) Chinese trial on isolated systolic hypertension in the elderly. Arch Intern Med 160:211–220
Wasnich RD, Davies JW, He YF, Petrovich H, Ross PD (1995) A randomized, double-masked, placebo-controlled trial of chlorthalidone and bone loss in elderly women. Osteoporosis Int 5:247–251
Wells TG (1999) Trials of antihypertensive therapies in children. Blood Press Monit 4:189–192
Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH, Kostis JB, Kumanyika S, Lacy CR, Johnson KC, Folmar S, Cutler JA (1998) Sodium reduction and weight loss in the treatment of hypertension in older persons. A randomized controlled trial of non-pharmacologic interventions in the elderly (TONE). JAMA 279:839–846
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2001 Steinkopff Verlag Darmstadt
About this chapter
Cite this chapter
Stimpel, M. (2001). Antihypertensive Therapie in speziellen Populationen. In: Arterielle Hypertonie. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57617-1_33
Download citation
DOI: https://doi.org/10.1007/978-3-642-57617-1_33
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-642-63309-6
Online ISBN: 978-3-642-57617-1
eBook Packages: Springer Book Archive